Drug Type Biosimilar, Colony-stimulating factors |
Synonyms Molgramostim biosimilar, molgramostim follow-on biologic, Recombinant Human Granulocyte/Macrophage Colony-stimulating Factor + [7] |
Target |
Mechanism CSF-2R stimulants(Granulocyte-macrophage colony-stimulating factor receptor stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (31 Dec 1997), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Leukopenia | CN | 31 Dec 1997 | |
Myelodysplastic Syndromes | CN | 31 Dec 1997 | |
Neutropenia | CN | 31 Dec 1997 |
Not Applicable | - | - | SBRT+GM-CSF特尔立 | laqfyhozyh(bnfyfvcpip) = aufvgibibs hshgdusdpn (mpsznudvdn ) | - | 25 Sep 2021 | |
Phase 4 | 206 | (rhGM-CSF Group) | tnbngosurt(rvpghatygp) = qnfotixrjc qcdlioeofd (uoomlktnvt, amvdqvyovr - kxufsvgmgv) View more | - | 27 Oct 2014 | ||
(rhG-CSF Group) | tnbngosurt(rvpghatygp) = efxxbkcuru qcdlioeofd (uoomlktnvt, etdmpucenh - bclvsehdkd) View more |